All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Interleukin-4 and interleukin-4 receptor alpha polymorphisms in atopic dermatitis: A case-control study

Author(s): Faten Zahran, Yousri M.Hussein, Esmat Ashour, Magda Sayed, Sally M.Shalaby, Noha Bakr

Background: Several lines of evidence suggest that the interleukin-4 (IL- 4) is involved in the development of atopic diseases. Objective: To determinewhether IL-4 and IL-4Rá polymorphisms are associated with susceptibility to dermatitis in Egyptian children, and to evaluate their effects on serumimmunoglobulin E (IgE) and serumIL-4 levels. Methods:We genotyped three groups of children, consisting of 50 atopic dermatitis (AD) children, 50 non-AD children, and equal number of healthy controls, for IL-4 (–590C/T) and IL-4Rá (I50V) genes polymorphisms using PCR-RFLP assay. Total serumIgE and serumIL-4 levels were detected by ELISA. Results: There was a non significant association of IL-4 -590C/T polymorphismin children with non-AD or those withAD when compared with the controls (P= 0.8, 0.4 respectively).We identified a significant association between IL-4Rá I50V polymorphism and dermatitis susceptibility in AD (p= 0.002), whereas no such association was observed in non-AD group (p=0.7). Evidence of gene interactions between both polymorphisms was found. Furthermore, there was no relation between each polymorphism and serum IL-4 level (p>0.05 for each) while homozygosity for the risk alleles of IL-4 -590 C/T and IL-4RI50Vwere significantly associated with increased total IgE levels in all studied groups. Conclusion: In Egyptian children, the IL-4Rá (I50V) may play a role in susceptibility toAD. In addition, gene-gene interaction between the IL-4 - 590T and the IL-4Rá G allele significantly increases an individual’s susceptibility to AD. Both polymorphisms may be involved in the control of IgE production.


Share this       
Get the App